• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巴西药物警戒实践整合面临的挑战:医院药剂师的局限性。

Challenges to the consolidation of pharmacovigilance practices in Brazil: limitations of the hospital pharmacist.

作者信息

Andrade Paulo Henrique Santos, de Almeida Amanda Carvalho Barreiros, Dos Santos Ana Keilla Santana, Lobo Iza Maria Fraga, da Silva Francilene Amaral, da Silva Wellington Barros

机构信息

Departamento de Farmácia, Universidade Federal de Sergipe, Núcleo de Pesquisa em Produtos Naturais e Assistência Farmacêutica (NUPPNAF), Av. Marechal Rondon, S/n - Jardim Rosa Elze, São Cristóvão, SE 49100-000, Brazil.

Nucleus of Research in Natural Products and Pharmaceutical Care, Federal University of Sergipe, São Cristóvão, Sergipe, Brazil.

出版信息

Ther Adv Drug Saf. 2020 Jul 31;11:2042098620933748. doi: 10.1177/2042098620933748. eCollection 2020.

DOI:10.1177/2042098620933748
PMID:32864089
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7430076/
Abstract

AIMS

The aim of this study was to present the needs of hospital pharmacists in pharmacovigilance practices.

METHODS

This study has a cross-sectional design and was carried out with hospital pharmacists in Brazil. The sample was obtained by voluntary recruitment. Pharmacists who worked at Brazilian hospitals and were registered in their respective regulatory councils were invited to participate in the present study. A personalized questionnaire was developed by the authors and was electronically filled out by the respondents on the platform 'Google forms'. The questionnaire was nationally available on the digital platform of the Pharmacy Federal Council, the Brazilian Society of Hospital Pharmacy and Health Services, four Pharmacy regional councils and the social network farmacêuticoclínico. Quantitative variables were analyzed by mean and standard deviation. The qualitative variables were analyzed by means of absolute and relative frequency. Difficulties related to pharmacovigilance activities are presented in an Ishikawa diagram in the Supplemental Material online.

RESULTS

Of the 27 federative units of Brazil, we obtained answers from pharmacists located in 85.2% ( = 23) of them. Among the pharmacovigilance practices developed by Brazilian pharmacists, the adverse drug reaction investigation (55.4%) and notification activities (47.0%) were worthy of note. Numerous difficulties were reported by the pharmacists, highlighting the difficulty in monitoring the medication and imputation of causality (27.7%). After categorizing the difficulties reported, it was observed that the category 'people involved' (45.1%) stood out from the others.

CONCLUSION

This study pointed out numerous challenges to pharmacovigilance practices involving pharmacists in Brazil. It is believed that the correction of certain difficulties may impact on the better consolidation of pharmacovigilance activities in the country. However, regulatory agencies at all hierarchical levels of pharmacovigilance must work together to make it possible.

PLAIN LANGUAGE SUMMARY

This is a study that seeks to present the needs of Brazilian hospital pharmacists in relation to pharmacovigilance activities. Through online interviews, pharmacists answered a questionnaire, presented the pharmacovigilance activities they develop and expressed their anxieties and difficulties for the development of these activities. With this study, it was concluded that numerous activities of active search, investigation and notification of adverse drug reaction are developed by Brazilian pharmacists. However, each pharmacist performs a different method of pharmacovigilance. In addition, it was observed that among the interviewees there was a perception of insufficient professional training and a shortage of professionals to assist in pharmacovigilance activities. These were the main difficulties reported. Therefore, the search for models or agile solutions to solve problems involving adverse drug reactions seems necessary for a better consolidation of pharmacovigilance services in Brazil.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71ee/7430076/24177f2ecf93/10.1177_2042098620933748-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71ee/7430076/8f0dcd0201c6/10.1177_2042098620933748-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71ee/7430076/24177f2ecf93/10.1177_2042098620933748-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71ee/7430076/8f0dcd0201c6/10.1177_2042098620933748-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71ee/7430076/24177f2ecf93/10.1177_2042098620933748-fig2.jpg
摘要

目的

本研究旨在呈现医院药剂师在药物警戒实践中的需求。

方法

本研究采用横断面设计,在巴西的医院药剂师中开展。样本通过自愿招募获得。邀请在巴西医院工作并在各自监管委员会注册的药剂师参与本研究。作者编制了一份个性化问卷,由受访者在“谷歌表单”平台上以电子方式填写。该问卷在巴西药学联邦委员会、巴西医院药学与卫生服务协会、四个药学区域委员会以及社交网络“临床药师”的数字平台上全国通用。定量变量通过均值和标准差进行分析。定性变量通过绝对频率和相对频率进行分析。与药物警戒活动相关的困难在在线补充材料的石川图中呈现。

结果

在巴西的27个联邦单位中,我们收到了来自其中85.2%(即23个)单位药剂师的回复。在巴西药剂师开展的药物警戒实践中,药品不良反应调查(55.4%)和报告活动(47.0%)值得关注。药剂师报告了诸多困难,其中突出的是监测用药和因果关系判定方面的困难(27.7%)。在对报告的困难进行分类后,发现“相关人员”类别(45.1%)比其他类别更为突出。

结论

本研究指出了巴西涉及药剂师的药物警戒实践面临的诸多挑战。相信纠正某些困难可能会对该国药物警戒活动的更好巩固产生影响。然而,药物警戒各级监管机构必须共同努力才能实现这一点。

通俗易懂的总结

这是一项旨在呈现巴西医院药剂师在药物警戒活动方面需求的研究。通过在线访谈,药剂师回答了一份问卷,介绍了他们开展的药物警戒活动,并表达了他们在开展这些活动时的担忧和困难。通过这项研究得出结论,巴西药剂师开展了大量主动搜索、调查和报告药品不良反应的活动。然而,每位药剂师开展药物警戒的方法各不相同。此外,观察到受访者中存在专业培训不足以及协助药物警戒活动的专业人员短缺的看法。这些是报告的主要困难。因此,寻求解决涉及药品不良反应问题的模式或灵活解决方案,对于巴西更好地巩固药物警戒服务似乎是必要的。

相似文献

1
Challenges to the consolidation of pharmacovigilance practices in Brazil: limitations of the hospital pharmacist.巴西药物警戒实践整合面临的挑战:医院药剂师的局限性。
Ther Adv Drug Saf. 2020 Jul 31;11:2042098620933748. doi: 10.1177/2042098620933748. eCollection 2020.
2
[Knowledge and attitude about Pharmacovigilance practices of pharmacy professionals of community pharmacy and hospital pharmacy in Spain.].[西班牙社区药房和医院药房药学专业人员对药物警戒实践的知识与态度。]
Rev Esp Salud Publica. 2020 Jul 16;94:e202007068.
3
[Hospital pharmacists' perception of pharmacovigilance in Quebec].[魁北克医院药剂师对药物警戒的认知]
Ann Pharm Fr. 2016 Mar;74(2):137-45. doi: 10.1016/j.pharma.2015.07.001. Epub 2015 Aug 17.
4
Reporting adverse drug reactions: contribution, knowledge and perception of German pharmacy professionals.药品不良反应报告:德国药学专业人员的贡献、知识与认知
Int J Clin Pharm. 2018 Aug;40(4):842-851. doi: 10.1007/s11096-018-0671-3. Epub 2018 Jun 16.
5
Medication safety knowledge, attitudes and practices among community pharmacists in Lebanon.黎巴嫩社区药剂师的用药安全知识、态度与实践
Curr Med Res Opin. 2018 Jan;34(1):149-156. doi: 10.1080/03007995.2017.1361916. Epub 2017 Aug 30.
6
Safety of medicines-Pharmacists' knowledge, practice, and attitudes toward pharmacovigilance and adverse drug reactions reporting process.药品安全 - 药剂师对药物警戒和药物不良反应报告流程的知识、实践和态度。
Pharmacoepidemiol Drug Saf. 2019 Dec;28(12):1543-1551. doi: 10.1002/pds.4792. Epub 2019 May 30.
7
[Clinical pharmacy and pharmacovigilance over a period of nine years in hospital].[医院九年期间的临床药学与药物警戒]
Therapie. 2012 May-Jun;67(3):243-50. doi: 10.2515/therapie/2012032. Epub 2012 Aug 9.
8
Impact of a pharmacist-driven pharmacovigilance system in a secondary hospital in the Gauteng Province of South Africa.南非豪登省一家二级医院中由药剂师主导的药物警戒系统的影响。
Hosp Pract (1995). 2018 Oct;46(4):221-228. doi: 10.1080/21548331.2018.1510708. Epub 2018 Sep 11.
9
Adverse drug reactions' reporting in a Mexican hospital.药品不良反应报告在墨西哥一家医院。
Int J Pharm Pract. 2020 Dec;28(6):660-662. doi: 10.1111/ijpp.12639. Epub 2020 May 31.
10
A global view of undergraduate education in pharmacovigilance.药物警戒本科教育的全球视野。
Eur J Clin Pharmacol. 2017 Jul;73(7):891-899. doi: 10.1007/s00228-017-2237-z. Epub 2017 Mar 17.

引用本文的文献

1
Pharmacy practice and policy research in Türkiye: a systematic review of literature.土耳其的药学实践与政策研究:文献系统综述
J Pharm Policy Pract. 2024 Aug 12;17(1):2385939. doi: 10.1080/20523211.2024.2385939. eCollection 2024.
2
Impact of the Role of the Clinical Pharmacist on the Underreporting of Adverse Drug Reactions at a Peruvian hospital.临床药师的作用对秘鲁一家医院药品不良反应漏报情况的影响
Hosp Pharm. 2023 Jun;58(3):295-303. doi: 10.1177/00185787221138006. Epub 2022 Dec 20.
3
Causality assessment of adverse drug reactions by applying a global introspection method in a high complexity hospital.

本文引用的文献

1
Assessing knowledge, attitude, and practices of health-care providers toward pharmacovigilance and adverse drug reaction reporting at a comprehensive cancer center in Jordan.评估约旦一家综合癌症中心医护人员对药物警戒和药品不良反应报告的知识、态度及实践情况。
Perspect Clin Res. 2019 Jul-Sep;10(3):115-120. doi: 10.4103/picr.PICR_4_18.
2
Canadian expert consensus: management of hypersensitivity reactions to intravenous iron in adults.加拿大专家共识:成人静脉注射铁剂过敏反应的管理
Vox Sang. 2019 May;114(4):363-373. doi: 10.1111/vox.12773. Epub 2019 Apr 2.
3
Harmonization of Pharmacovigilance Regulation in Brazil: Opportunities to Improve Risk Communication.
在一家高复杂性医院中应用全局自省方法对药物不良反应进行因果关系评估。
Explor Res Clin Soc Pharm. 2021 Sep 2;3:100064. doi: 10.1016/j.rcsop.2021.100064. eCollection 2021 Sep.
巴西药物警戒法规的协调统一:改善风险沟通的机会。
Clin Ther. 2019 Mar;41(3):598-603. doi: 10.1016/j.clinthera.2019.01.013. Epub 2019 Feb 18.
4
Trigger tools are as effective as non-targeted chart review for adverse drug event detection in intensive care units.在重症监护病房中,触发工具在检测药物不良事件方面与非针对性病历审查同样有效。
Saudi Pharm J. 2018 Dec;26(8):1155-1161. doi: 10.1016/j.jsps.2018.07.003. Epub 2018 Jul 20.
5
Pharmacovigilance: Challenges in Getting From Here to There.
Clin Ther. 2018 Dec;40(12):1964-1966. doi: 10.1016/j.clinthera.2018.10.020. Epub 2018 Nov 23.
6
Evolution and key elements of the Brazilian pharmacovigilance system: a scoping review beginning with the creation of the Brazilian Health Regulatory Agency.巴西药物警戒系统的演变与关键要素:一项从巴西卫生监管机构创建开始的范围综述
Cad Saude Publica. 2018 Oct 11;34(10):e00000218. doi: 10.1590/0102-311X00000218.
7
Healthcare Professional's Perception of Patient Safety Measured by the Hospital Survey on Patient Safety Culture: A Systematic Review and Meta-Analysis.通过医院患者安全文化调查衡量医疗保健专业人员对患者安全的认知:一项系统评价和荟萃分析
ScientificWorldJournal. 2018 Jul 19;2018:9156301. doi: 10.1155/2018/9156301. eCollection 2018.
8
National Patient Safety Program in Brazil: Incidents Reported Between 2014 and 2017.巴西国家患者安全计划:2014 年至 2017 年报告的事件。
J Patient Saf. 2021 Dec 1;17(8):e1202-e1208. doi: 10.1097/PTS.0000000000000496.
9
Pharmacovigilance: pharmacists' perspective on spontaneous adverse drug reaction reporting.药物警戒:药剂师对自发上报药品不良反应的看法
Integr Pharm Res Pract. 2017 Mar 22;6:91-98. doi: 10.2147/IPRP.S105881. eCollection 2017.
10
Hospital pharmacy workforce in Brazil.巴西医院药剂师队伍。
Hum Resour Health. 2018 Jan 4;16(1):1. doi: 10.1186/s12960-017-0265-5.